does semaglutide cause kidney damage in Diabetic Disease: Integrating Clinical Evidence with Mechanistic Insights Saving kidneys, hearts and lives':

if peri-operative planning is relevant

braces for increased wildfire activity04:16 | July 15, 2026 BIV: Bank of Canada interest rate decision02:26 | July 15, 2026 Metro Vancouver gas prices going up01:52 | July 15, 2026 Health Matters: Summer Seasonal Affective Disorder04:02 | July 14, 2026 Vancouver Mayor changes course on fate of Vancouver Park Board05:25 | July 14, 2026 MNP Survey: British Columbians caught in pre-spent paycheque cycle04:03 | July 14, 2026 North Vancouver Mayors call for provincial inquiry into North Shore Wastewater Treatment Plant05:36 | July 13, 2026 Tech Talk: Apple sues OpenAI03:49 | July 13, 2026 Palmas Picks: Summer travel with kids05:18 | July 12, 2026 Canada adds 18,000 jobs in June04:30 | July 12, 2026 Beating the summer blues05:01 | July 12, 2026 Cooking Together: Desis street food06:54 | July 12, 2026 Saturday Sips: Summer sips French style05:31 | July 11, 2026 U.S

A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study

Our real-world results differ from those observed in clinical trials

What the Clinical Evidence Shows About GLP-1 and Thyroid Nodules The FDA issued a class warning for GLP-1 agonists based on animal studies showing medullary thyroid carcinoma (MTC) risk at supratherapeutic doses